Neural Markers in Lung Cancer
Author Information
Author(s): A.P. Dhillon, J. Rode, D.P. Dhillon, E. Moss, R.J. Thompson, S.G. Spiro, B. Corrin
Primary Institution: The Bland-Sutton Institute of Pathology, The Middlesex Hospital Medical School, London
Hypothesis
The study aims to determine if neural markers have diagnostic, prognostic, or therapeutic implications in lung carcinoma.
Conclusion
Neuroendocrine markers are of little value in differentiating small cell carcinoma from non-small cell carcinoma, and positive staining for NSE may indicate prolonged survival in small cell carcinoma.
Supporting Evidence
- Positive staining for NSE in small cell carcinoma may indicate a longer survival time.
- All non-small cell carcinoma cases showed positive reactions to all three markers.
- Cases with positive NSE reactions had a mean survival of 9.1 months compared to 3.9 months for negative reactions.
Takeaway
The study looked at markers in lung cancer to see if they could help doctors tell different types of lung cancer apart, but they found that these markers don't really help.
Methodology
The study examined endobronchial biopsy specimens and lung tumor resection specimens using immunohistochemistry to assess the expression of neural markers.
Limitations
The small sample size limits the ability to assign statistical significance to the findings.
Participant Demographics
The study included 20 patients with lung carcinoma, consisting of 12 cases of small cell carcinoma and 8 cases of non-small cell carcinoma.
Want to read the original?
Access the complete publication on the publisher's website